Terms & Disclaimer
Last updated: August 2026
Important Disclaimer
Pipette Dreams is a research and information platform. Nothing on this platform is investment advice, a recommendation, or an offer or solicitation to buy, sell, or hold any security.
1. No Investment Advice
Pipette Dreams is an informational and research tool. The content, scores, valuations, analyses, catalyst timelines, and data provided on this platform (collectively, "Content") are generated by artificial intelligence based on publicly available data and are provided for informational and educational purposes only. None of the Content constitutes, or should be construed as, investment advice, financial advice, trading advice, a recommendation, or any other type of professional advice. You should not rely on any Content as the sole basis for any investment decision.
2. Not a Registered Securities Professional
Pipette Dreams is not a registered investment adviser, broker-dealer, financial analyst, or any other type of financial professional, and does not hold any securities licenses or registrations with the SEC, FINRA, or any state regulator. The platform does not offer personalized investment recommendations tailored to your specific financial situation, risk tolerance, investment objectives, or portfolio.
3. No Solicitation or Offer
The Content is not, and should not be interpreted as, an offer to buy, sell, or solicit the purchase or sale of any security, or as a solicitation of any vote, proxy, or authorization. The mention of any company, ticker, drug program, or clinical trial is for informational purposes only and does not indicate that any security is suitable for any investor. Pipette Dreams does not execute trades, hold client assets, or facilitate transactions of any kind.
4. Impersonal, Non-Tailored Content
All Content is impersonal, general, and published to all users without regard to any individual's circumstances. It is not tailored to you or to any specific investor, and Pipette Dreams does not consider your financial situation, objectives, or risk tolerance in producing it. Any similarity between the Content and advice that would be suitable for you is coincidental and not the result of any personalized analysis.
5. AI-Generated Estimates, Not Ratings
Scores (including Clinical Strength, Regulatory Confidence, and Investment Opportunity scores), conviction rankings, upside and downside estimates, and revenue scenarios are statistical, analytical estimates produced by automated models. They are not investment ratings, credit ratings, or analyst recommendations, and they carry no regulatory or institutional standing. A high score does not imply that a security will perform well, and a low score does not imply that it will perform poorly. Scores may change without notice as underlying data or models change.
6. Hypothetical and Historical Performance Only
Any options backtest, entry-timing analysis, price-event study, or calibration output is hypothetical and based on historical data and simplified modeling assumptions (for example, modeled option prices rather than executed trades). Hypothetical performance has inherent limitations and does not represent actual trading. Past performance — whether real or modeled — does not guarantee, predict, or indicate future results. There is no representation that any modeled strategy would have been profitable if actually executed, or that it will be profitable in the future.
7. Accuracy, AI Limitations & No Warranty
All scores, evaluations, and analyses are generated by AI models. AI-generated content may contain errors, inaccuracies, or outdated information, and may misinterpret data, miss important context, or produce conclusions that differ from those of a trained professional. The platform and all Content are provided "as is" and "as available" without any warranties of any kind, whether express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, or non-infringement. No representation or warranty is made as to the accuracy, completeness, timeliness, or reliability of any Content.
8. High-Risk Asset Class
Biotechnology equities are among the highest-risk securities available. Clinical trials frequently fail, regulatory approvals are often denied, and biotechnology companies frequently experience significant stock price volatility, dilution, and bankruptcy. You may lose your entire investment in any biotechnology security. Past performance of any drug program, clinical trial, or stock does not guarantee future results.
9. Forward-Looking Statements
The platform may contain forward-looking statements, projections, and estimates regarding drug development timelines, regulatory outcomes, commercial opportunities, and stock valuations. These forward-looking statements are inherently uncertain and are based on assumptions that may prove incorrect. Actual results may differ materially from any projections provided.
10. Independent Verification
You are responsible for independently verifying any Content before acting on it, including reviewing original sources such as ClinicalTrials.gov, SEC filings, company press releases, and peer-reviewed literature. Pipette Dreams aggregates and synthesizes third-party data and does not control, endorse, or guarantee the accuracy of those underlying sources.
11. No Fiduciary Relationship
Your use of this platform creates no fiduciary, advisory, or agency relationship between you and Pipette Dreams or its operators. We owe you no duty of care, loyalty, or prudence with respect to any investment decision, and nothing on the platform creates any such duty.
12. Limitation of Liability
To the fullest extent permitted by law, Pipette Dreams and its operators shall not be liable for any direct, indirect, incidental, consequential, special, or punitive damages arising from your use of, or reliance on, the platform or any Content. This includes, without limitation, any losses or damages arising from investment decisions made in reliance on Content provided on this platform.
13. Indemnification
You agree to indemnify and hold harmless Pipette Dreams and its operators from any claims, losses, or damages (including reasonable legal fees) arising from your use of the platform or your reliance on any Content, to the extent permitted by applicable law.
14. Consult a Licensed Professional
You should consult with a licensed financial advisor, attorney, or tax professional before making any investment decisions. You are solely responsible for your own investment decisions and for any gains or losses you may experience.
15. Subscription, Auto-Renewal & Billing
Pipette Dreams Pro is offered as a recurring monthly subscription billed at $10/month or an annual subscription billed at $60/year (equivalent to $5/month). Your subscription automatically renews each billing period (monthly or annually, depending on your selected plan) until you cancel. You may cancel at any time from your account page; cancellation takes effect at the end of the current billing cycle, and you will retain access until then. No refunds are provided for partial billing periods. Subscription fees are for access to the platform's research features and do not constitute payment for investment advice or personalized recommendations.
16. Acceptance
By using this platform, you acknowledge that you have read, understood, and agree to these terms. If you do not agree with any part of this disclaimer, you should not use the platform.